Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 74

    1.

    Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy.

    Ferder N, Eby CS, Deych E, Harris JK, Ridker PM, Milligan P, Goldhaber SZ, King CR, Giri T, McLeod HL, Glynn RJ, Gage BF.

    J Thromb Haemost. 2009 Oct 30. [Epub ahead of print]PMID: 19874474 [PubMed - as supplied by publisher]Related articles

    2.

    Can we rely on RE-LY?

    Gage BF.

    N Engl J Med. 2009 Sep 17;361(12):1200-2. Epub 2009 Aug 30. No abstract available. PMID: 19717843 [PubMed - indexed for MEDLINE]Related articles

    3.

    Interactive modeling for ongoing utility of pharmacogenetic diagnostic testing: application for warfarin therapy.

    Linder MW, Bon Homme M, Reynolds KK, Gage BF, Eby C, Silvestrov N, Valdes R Jr.

    Clin Chem. 2009 Oct;55(10):1861-8. Epub 2009 Aug 13.PMID: 19679631 [PubMed - indexed for MEDLINE]Related articles

    4.

    Anemia: an independent predictor of death and hospitalizations among elderly patients with atrial fibrillation.

    Sharma S, Gage BF, Deych E, Rich MW.

    Am Heart J. 2009 Jun;157(6):1057-63. Epub 2009 Apr 25.PMID: 19464417 [PubMed - indexed for MEDLINE]Related articles

    5.

    Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score.

    Subherwal S, Bach RG, Chen AY, Gage BF, Rao SV, Newby LK, Wang TY, Gibler WB, Ohman EM, Roe MT, Pollack CV Jr, Peterson ED, Alexander KP.

    Circulation. 2009 Apr 14;119(14):1873-82. Epub 2009 Mar 30.PMID: 19332461 [PubMed - indexed for MEDLINE]Related articles

    6.

    Estimation of the warfarin dose with clinical and pharmacogenetic data.

    International Warfarin Pharmacogenetics Consortium, Klein TE, Altman RB, Eriksson N, Gage BF, Kimmel SE, Lee MT, Limdi NA, Page D, Roden DM, Wagner MJ, Caldwell MD, Johnson JA.

    N Engl J Med. 2009 Feb 19;360(8):753-64. Erratum in: N Engl J Med. 2009 Oct 15;361(16):1613. Dosage error in article text. PMID: 19228618 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation.

    Eckman MH, Rosand J, Greenberg SM, Gage BF.

    Ann Intern Med. 2009 Jan 20;150(2):73-83.PMID: 19153410 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients.

    Lenzini PA, Grice GR, Milligan PE, Dowd MB, Subherwal S, Deych E, Eby CS, King CR, Porche-Sorbet RM, Murphy CV, Marchand R, Millican EA, Barrack RL, Clohisy JC, Kronquist K, Gatchel SK, Gage BF.

    J Thromb Haemost. 2008 Oct;6(10):1655-62. Epub 2008 Jul 24.PMID: 18662264 [PubMed - indexed for MEDLINE]Related articles

    9.

    Dosing anticoagulant therapy with coumarin drugs: is genotyping clinically useful? Yes.

    Thacker SM, Grice GR, Milligan PE, Gage BF.

    J Thromb Haemost. 2008 Sep;6(9):1445-9. Epub 2008 Jul 8. Review. No abstract available. PMID: 18627440 [PubMed - indexed for MEDLINE]Related articles

    10.

    Performance of commercial platforms for rapid genotyping of polymorphisms affecting warfarin dose.

    King CR, Porche-Sorbet RM, Gage BF, Ridker PM, Renaud Y, Phillips MS, Eby C.

    Am J Clin Pathol. 2008 Jun;129(6):876-83.PMID: 18480003 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin.

    Gage BF, Eby C, Johnson JA, Deych E, Rieder MJ, Ridker PM, Milligan PE, Grice G, Lenzini P, Rettie AE, Aquilante CL, Grosso L, Marsh S, Langaee T, Farnett LE, Voora D, Veenstra DL, Glynn RJ, Barrett A, McLeod HL.

    Clin Pharmacol Ther. 2008 Sep;84(3):326-31. Epub 2008 Feb 27. Erratum in: Clin Pharmacol Ther. 2008 Sep;84(3):430. PMID: 18305455 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    CYP4F2 genetic variant alters required warfarin dose.

    Caldwell MD, Awad T, Johnson JA, Gage BF, Falkowski M, Gardina P, Hubbard J, Turpaz Y, Langaee TY, Eby C, King CR, Brower A, Schmelzer JR, Glurich I, Vidaillet HJ, Yale SH, Qi Zhang K, Berg RL, Burmester JK.

    Blood. 2008 Apr 15;111(8):4106-12. Epub 2008 Feb 4.PMID: 18250228 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Pharmacogenetic dose refinement prevents warfarin overdose in a patient who is highly warfarin-sensitive.

    Grice GR, Milligan PE, Eby C, Gage BF.

    J Thromb Haemost. 2008 Jan;6(1):207-9. Epub 2007 Oct 12. No abstract available. PMID: 17944998 [PubMed - indexed for MEDLINE]Related articles

    14.

    Optimal initial dose adjustment of warfarin in orthopedic patients.

    Lenzini PA, Grice GR, Milligan PE, Gatchel SK, Deych E, Eby CS, Burnett RS, Clohisy JC, Barrack RL, Gage BF.

    Ann Pharmacother. 2007 Nov;41(11):1798-804. Epub 2007 Oct 2.PMID: 17911206 [PubMed - indexed for MEDLINE]Related articles

    15.

    Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues.

    Gage BF, Lesko LJ.

    J Thromb Thrombolysis. 2008 Feb;25(1):45-51. Epub 2007 Oct 1. Review.PMID: 17906972 [PubMed - indexed for MEDLINE]Related articles

    16.

    Can patients at elevated risk of stroke treated with anticoagulants be further risk stratified?

    Baruch L, Gage BF, Horrow J, Juul-Möller S, Labovitz A, Persson M, Zabalgoitia M.

    Stroke. 2007 Sep;38(9):2459-63. Epub 2007 Aug 2.PMID: 17673721 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Genetic-based dosing in orthopedic patients beginning warfarin therapy.

    Millican EA, Lenzini PA, Milligan PE, Grosso L, Eby C, Deych E, Grice G, Clohisy JC, Barrack RL, Burnett RS, Voora D, Gatchel S, Tiemeier A, Gage BF.

    Blood. 2007 Sep 1;110(5):1511-5. Epub 2007 Mar 26.PMID: 17387222 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Anemia does not predict mortality in elderly patients with heart failure.

    Kerzner R, Gage BF, Rich MW.

    Am J Geriatr Cardiol. 2007 Mar-Apr;16(2):92-6.PMID: 17380618 [PubMed - indexed for MEDLINE]Related articles

    19.

    An invasive strategy is associated with decreased mortality in patients 80 years and older with acute myocardial infarction.

    Schloss TW, Gage BF, Rich MW.

    Am J Geriatr Cardiol. 2007 Mar-Apr;16(2):84-91.PMID: 17380617 [PubMed - indexed for MEDLINE]Related articles

    20.

    Improving adherence to coronary heart disease secondary prevention medication guidelines at a community hospital.

    Bailey TC, Noirot LA, Gage BF, Li X, Shannon WD, Waterman B, Sinha S, Bouselli DA, Reichley RM, Goldberg AC, Dunagan WC.

    AMIA Annu Symp Proc. 2006:850.PMID: 17238470 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Pharmacogenetics-based coumarin therapy.

    Gage BF.

    Hematology Am Soc Hematol Educ Program. 2006:467-73. Review.PMID: 17124101 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Construction and validation of an automated model for the early identification of patients hospitalized for heart failure.

    Krainik AJ, Reichley RM, Gage BF, Dunagan WC, Bailey TC.

    AMIA Annu Symp Proc. 2005:1010.PMID: 16779297 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation.

    Birman-Deych E, Radford MJ, Nilasena DS, Gage BF.

    Stroke. 2006 Apr;37(4):1070-4. Epub 2006 Mar 9.PMID: 16528001 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).

    Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich MW, Radford MJ.

    Am Heart J. 2006 Mar;151(3):713-9.PMID: 16504638 [PubMed - indexed for MEDLINE]Related articles

    25.

    Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2.

    Gage BF, Birman-Deych E, Radford MJ, Nilasena DS, Binder EF.

    Arch Intern Med. 2006 Jan 23;166(2):241-6.PMID: 16432096 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Is primary care ready for pharmacogenetics?

    Voora D, Gage BF.

    Pharmacogenomics. 2006 Jan;7(1):1-3. No abstract available. PMID: 16354118 [PubMed - indexed for MEDLINE]Related articles

    27.

    Use of EPO in critically ill patients with acute renal failure requiring renal replacement therapy.

    Park J, Gage BF, Vijayan A.

    Am J Kidney Dis. 2005 Nov;46(5):791-8.PMID: 16253718 [PubMed - indexed for MEDLINE]Related articles

    28.

    Comorbidity indices to predict mortality from Medicare data: results from the national registry of atrial fibrillation.

    Yan Y, Birman-Deych E, Radford MJ, Nilasena DS, Gage BF.

    Med Care. 2005 Nov;43(11):1073-7.PMID: 16224299 [PubMed - indexed for MEDLINE]Related articles

    29.

    Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision making.

    Man-Son-Hing M, Gage BF, Montgomery AA, Howitt A, Thomson R, Devereaux PJ, Protheroe J, Fahey T, Armstrong D, Laupacis A.

    Med Decis Making. 2005 Sep-Oct;25(5):548-59.PMID: 16160210 [PubMed - indexed for MEDLINE]Related articles

    30.

    Pharmacology and pharmacogenetics of warfarin and other coumarins when used with supplements.

    Gage BF, Milligan PE.

    Thromb Res. 2005;117(1-2):55-9; discussion 65-7. Epub 2005 Jul 25. Review. No abstract available. PMID: 16043212 [PubMed - indexed for MEDLINE]Related articles

    31.

    The pharmacogenetics of coumarin therapy.

    Voora D, McLeod HL, Eby C, Gage BF.

    Pharmacogenomics. 2005 Jul;6(5):503-13. Review.PMID: 16014000 [PubMed - indexed for MEDLINE]Related articles

    32.

    Reliability for grading acute rejection and airway inflammation after lung transplantation.

    Chakinala MM, Ritter J, Gage BF, Aloush AA, Hachem RH, Lynch JP, Patterson GA, Trulock EP.

    J Heart Lung Transplant. 2005 Jun;24(6):652-7.PMID: 15949723 [PubMed - indexed for MEDLINE]Related articles

    33.

    Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.

    Rieder MJ, Reiner AP, Gage BF, Nickerson DA, Eby CS, McLeod HL, Blough DK, Thummel KE, Veenstra DL, Rettie AE.

    N Engl J Med. 2005 Jun 2;352(22):2285-93.PMID: 15930419 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall.

    Gage BF, Birman-Deych E, Kerzner R, Radford MJ, Nilasena DS, Rich MW.

    Am J Med. 2005 Jun;118(6):612-7.PMID: 15922692 [PubMed - indexed for MEDLINE]Related articles

    35.

    Implantable cardioverter-defibrillator therapy improves long-term survival in patients with unexplained syncope, cardiomyopathy, and a negative electrophysiologic study.

    Sánchez JM, Katsiyiannis WT, Gage BF, Chen J, Faddis MN, Gleva MJ, Smith TW, Lindsay BD.

    Heart Rhythm. 2005 Apr;2(4):367-73.PMID: 15851337 [PubMed - indexed for MEDLINE]Related articles

    36.

    Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype.

    Voora D, Eby C, Linder MW, Milligan PE, Bukaveckas BL, McLeod HL, Maloney W, Clohisy J, Burnett RS, Grosso L, Gatchel SK, Gage BF.

    Thromb Haemost. 2005 Apr;93(4):700-5.PMID: 15841315 [PubMed - indexed for MEDLINE]Related articles

    37.

    Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors.

    Birman-Deych E, Waterman AD, Yan Y, Nilasena DS, Radford MJ, Gage BF.

    Med Care. 2005 May;43(5):480-5.PMID: 15838413 [PubMed - indexed for MEDLINE]Related articles

    38.

    Costs and effectiveness of ximelagatran for stroke prophylaxis in chronic atrial fibrillation.

    O'Brien CL, Gage BF.

    JAMA. 2005 Feb 9;293(6):699-706.PMID: 15701911 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Simplified peak power reserve in patients with an implantable cardioverter-defibrillator and advanced heart failure.

    Katsiyiannis WT, Waggoner AD, Barzilai B, Gage BF, Sanchez JM, Rogers JG, Lindsay BD, Gleva MJ.

    Am J Cardiol. 2005 Jan 15;95(2):286-8.PMID: 15642573 [PubMed - indexed for MEDLINE]Related articles

    40.

    Yield of surveillance bronchoscopy for acute rejection and lymphocytic bronchitis/bronchiolitis after lung transplantation.

    Chakinala MM, Ritter J, Gage BF, Lynch JP, Aloush A, Patterson GA, Trulock EP.

    J Heart Lung Transplant. 2004 Dec;23(12):1396-404.PMID: 15607670 [PubMed - indexed for MEDLINE]Related articles

    41.

    Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.

    Gage BF, van Walraven C, Pearce L, Hart RG, Koudstaal PJ, Boode BS, Petersen P.

    Circulation. 2004 Oct 19;110(16):2287-92. Epub 2004 Oct 11.PMID: 15477396 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant.

    Yen EF, Hardinger K, Brennan DC, Woodward RS, Desai NM, Crippin JS, Gage BF, Schnitzler MA.

    Am J Transplant. 2004 Oct;4(10):1703-8.PMID: 15367228 [PubMed - indexed for MEDLINE]Related articles

    43.

    Effect of age on the incidence of venous thromboembolism after major surgery.

    White RH, Zhou H, Gage BF.

    J Thromb Haemost. 2004 Aug;2(8):1327-33.PMID: 15304038 [PubMed - indexed for MEDLINE]Related articles

    44.

    Effect of warfarin nonadherence on control of the International Normalized Ratio.

    Waterman AD, Milligan PE, Bayer L, Banet GA, Gatchel SK, Gage BF.

    Am J Health Syst Pharm. 2004 Jun 15;61(12):1258-64.PMID: 15259756 [PubMed - indexed for MEDLINE]Related articles

    45.

    Use of pharmacogenetics to guide warfarin therapy.

    Voora D, McLeod HL, Eby C, Gage BF.

    Drugs Today (Barc). 2004 Mar;40(3):247-57.PMID: 15148533 [PubMed - indexed for MEDLINE]Related articles

    46.

    The genetics of vitamin K antagonists.

    Gage BF, Eby CS.

    Pharmacogenomics J. 2004;4(4):224-5. No abstract available. PMID: 15148502 [PubMed - indexed for MEDLINE]Related articles

    47.

    The management of anticoagulants in the periendoscopic period for patients with atrial fibrillation: a decision analysis.

    Gerson LB, Triadafilopoulos G, Gage BF.

    Am J Med. 2004 Apr 1;116(7):451-9.PMID: 15047034 [PubMed - indexed for MEDLINE]Related articles

    48.

    Randomized trial of warfarin nomograms.

    Gage BF.

    Ann Intern Med. 2004 Mar 16;140(6):489; author reply 491-2. No abstract available. PMID: 15023721 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Pharmacogenetics and anticoagulant therapy.

    Gage BF, Eby CS.

    J Thromb Thrombolysis. 2003 Aug-Oct;16(1-2):73-8. Review.PMID: 14760217 [PubMed - indexed for MEDLINE]Related articles

    50.

    Perioperative reduction of the warfarin dose.

    Milligan PE, Banet GA, Gage BF.

    Am J Med. 2003 Dec 15;115(9):741-2. No abstract available. PMID: 14693332 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...